VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,816,765 | -72.8% | 727,615 | -28.9% | 0.00% | -75.0% |
| Q2 2023 | $25,090,503 | +2290.8% | 1,022,739 | +2167.7% | 0.01% | – |
| Q1 2023 | $1,049,477 | +91878.7% | 45,100 | 0.0% | 0.00% | – |
| Q4 2022 | $1,141 | -99.9% | 45,100 | 0.0% | 0.00% | – |
| Q3 2022 | $870,000 | -70.9% | 45,100 | -61.6% | 0.00% | -100.0% |
| Q2 2022 | $2,989,000 | -81.0% | 117,379 | -80.8% | 0.00% | -80.0% |
| Q1 2022 | $15,749,000 | +17.3% | 612,336 | +91.0% | 0.01% | +25.0% |
| Q4 2021 | $13,421,000 | +499.2% | 320,551 | +522.6% | 0.00% | +300.0% |
| Q3 2021 | $2,240,000 | +25.7% | 51,482 | +36.6% | 0.00% | 0.0% |
| Q2 2021 | $1,782,000 | -27.7% | 37,689 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $2,465,000 | +833.7% | 48,070 | +387.0% | 0.00% | – |
| Q4 2020 | $264,000 | -19.8% | 9,870 | +2.9% | 0.00% | – |
| Q3 2020 | $329,000 | – | 9,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |